Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

Overview of attention for article published in The Lancet, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 39 news outlets
blogs: 8 blogs
twitter: 343 X users
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page
video: 1 YouTube creator
bluesky: 3 Bluesky users
podcasts: 4 podcasts

Readers on

mendeley: 213 Mendeley

So far, Altmetric has seen 46 news stories from 39 outlets.

Managing Agitation in Alzheimer's Disease: 5 Things to Know

Medscape, 10 Jul 2024

Agitation is a neuropsychiatric symptom in patients with Alzheimer's disease (AD), the most common form of dementia.

Last Month in Neurology Research: Some Ups, Some Downs

Medscape, 01 Dec 2021

This transcript has been edited for clarity. Dear colleagues, I'm Christoph Diener from the medical faculty of the University…

Demenz: Antidepressivum Mirtazapin bleibt in Studie ohne Wirkung auf...

Deutsches Ärzteblatt, 29 Nov 2021

/Production Perig, stock.adobe.com Plymouth/England Das Antidepressivum Mirtazapin, das wegen seiner sedierenden Wirkung…

Antidepressivo é ineficaz para tratar agitação da demência, diz estudo

UOL, 09 Nov 2021

O antidepressivo mirtazapina, prescrito para tratar a agitação em pessoas com demência, não melhora o sintoma e estaria…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 42 additional news stories.